Globenewswire

Search documents
ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-09-25 21:43
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anika (ANIK) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Anika and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized ...
SLQT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages SelectQuote, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SLQT
Globenewswire· 2025-09-25 21:42
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SelectQuote, Inc. (NYSE: SLQT) between September 9, 2020 and May 1, 2025, both dates inclusive (the “Class Period”), of the important October 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased SelectQuote securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...
ENCOMPASS (EHC) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Encompass Health Corporation on Behalf of Encompass Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-09-25 21:39
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Encompass (EHC) To Contact Them Directly To Discuss Their Options If you purchased or acquired securities in Encompass and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized st ...
Firan Technology Group Corporation Announces Acceptance by TSX of Normal Course Issuer Bid Renewal
Globenewswire· 2025-09-25 21:30
TORONTO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Firan Technology Group Corporation (TSX: FTG) (OTCQX: FTGFF) (“FTG” or the “Corporation”) today announced the acceptance by the Toronto Stock Exchange (the “TSX”) of FTG’s Notice of Intention to Make a Normal Course Issuer Bid (“NCIB”), renewing the NCIB that expired in August 2025. Pursuant to the NCIB, FTG is authorized to purchase through the facilities of the TSX, from time to time over the next 12 months, if considered advisable, up to an aggregate of 1,258,6 ...
Medirom Decides to Double Installation of Authentication Device “Orb” to 200 Stores, in Collaboration with “World” Co-founded by Sam Altman and Alex Blania
Globenewswire· 2025-09-25 21:30
TOKYO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM), a diversified healthcare company, has joined “World,” a “proof of human” protocol co-founded by Sam Altman and Tools for Humanity’s CEO, Alex Blania. MEDIROM plans to complete the deployment of the World ID proof of human authentication device Orb across 100 of its Re.Ra.Ku relaxation studios in Japan within this month, and to expand the deployment to 200 location ...
EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States
Globenewswire· 2025-09-25 21:30
Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States EssilorLuxottica’s lens is clinically proven to slow myopia progression in children1,2 Paris, France (25 September 2025) – EssilorLuxottica today announced the U.S. Food and Drug Administration (FDA) has granted market authorization for its Essilor Stellest lens using the De Novo pathway. This follows the product’s earlier recognition with the FDA granting designation as a Breakthrough Device in 2021. The Essil ...
ABACUS (ABL) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Abacus Global Management, Inc. on Behalf of Abacus Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-09-25 21:28
If you purchased or acquired stock in Abacus and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ:ABL) on behalf of Abacus stoc ...
Uniti Group Inc. Announces Pricing of Upsized Senior Notes Offering
Globenewswire· 2025-09-25 21:25
Core Viewpoint - Uniti Group Inc. announced the pricing of a $1.4 billion offering of 7.50% Senior Secured Notes due 2033, which was upsized by $500 million from the initial offering size of $900 million [2] Group 1: Offering Details - The Notes will be issued at an issue price of 100.00% and will be guaranteed on a senior unsecured basis by Uniti Group Inc. and Uniti Group LLC [2] - The offering is expected to close on October 6, 2025 [2] - The Issuer is also pursuing $1.0 billion in incremental term loan borrowings under the legacy Windstream credit agreement [3] Group 2: Use of Proceeds - The net proceeds from the Offering and the borrowings under the 2025 Term Loan will be used to fund the redemption of outstanding 10.50% senior secured notes due 2028 [4] - Any remaining proceeds will be allocated for general corporate purposes [4] Group 3: Redemption Conditions - The redemption of the 2028 secured notes is conditioned upon the Issuer receiving at least $2.4 billion in gross proceeds from the offering of the Notes and the 2025 Term Loan [5] - The redemption will occur on October 6, 2025, at a price determined by the indenture governing the 2028 secured notes plus any accrued interest [5]
AVITA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-09-25 21:24
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avita (RCEL) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Avita and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized ...
Kuke Music Holding Limited Announces Strategic Acquisition of Controlling Interest in Naxos Music Group
Globenewswire· 2025-09-25 21:20
Core Viewpoint - Kuke Music Holding Limited has acquired a controlling interest in Naxos Music Group, enhancing its position in the classical music services market and expanding its global reach [1][12]. Transaction Overview - The acquisition was completed on September 17, 2025, with a total transaction value of approximately US$106.35 million, settled entirely through the issuance of Kuke's Class A ordinary shares [2]. - Kuke issued a total of 661,392,939 Class A ordinary shares as consideration for the acquisition [3]. Transaction Structure and Consideration - The shares were valued at US$0.1608 each, based on the average closing price of Kuke's American Depositary Shares for the 60 trading days prior to the transaction [3]. - The consideration may be settled in cash or through share issuance, with provisions for cash redemption under certain circumstances [4]. Shareholder Rights and Approvals - The transactions received approval from Kuke's shareholders, Board of Directors, and Audit Committee, following an independent valuation [6]. - Existing shareholders of Naxos One had preemptive rights regarding the issuance of Class B ordinary shares, which were not exercised before the deadline [7]. Acquisition Details - Kuke subscribed for 17,500 newly issued Class B ordinary shares at US$6,000 per share, totaling US$105 million, and acquired 108 Class A ordinary shares from Desun for US$1.35 million [8]. - Following the acquisition, Kuke holds approximately 70.43% of the outstanding shares of Naxos One, which controls Naxos Music Group [5]. Strategic Rationale - The acquisition is seen as a transformative step for Kuke, providing significant synergies between its music education platform and Naxos's extensive catalog and distribution network [12]. - Kuke aims to leverage Naxos's world-class content library to enhance its offerings and strengthen its market position [13]. About Naxos Music Group - Naxos Music Group, established in 1987, is a leading independent classical music organization with a vast catalog and global distribution capabilities [10][11]. - The company has pioneered digital music streaming and operates a comprehensive ecosystem for classical music, including educational services [11].